The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...

MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...

RedHill Biopharma has begun a trial to assess the combination of opaganib and darolutamide for metastatic castrate-resistant ...

Cumberland Pharmaceuticals has reported positive outcomes from a trial of ifetroban as a potential treatment for Duchenne ...

On World Cancer Day, the UK Government has announced plans to launch a national trial to cut cancer screening wait times.